Supply Chain Is Normalized. So Why the Higher Prices?

A practice collecting $1.2 million is now paying roughly $12,600 more a year for the same gloves, the same composite and the same crown-and-bridge work it bought in 2024. Nothing is broken. The freight normalized, the backorders cleared, the allocation emails stopped, and the prices stayed exactly where the shortage put them.

Here is the part owners will argue with: the fee increase you already took this year is not a fix. It is a one-time payment against a recurring bill, and on a heavily contracted book it collects at roughly a third of the rate you think it does. Two-thirds of dentists raised fees since the start of 2025, by an average of 6.7% among those who did, according to ADA News reporting on ADA Health Policy Institute data. Most of those owners booked that raise as the answer. It was closer to a bridge loan.

The Spike Became the Floor, and the Floor Is Still Rising

Start with what actually happened to the price level. ADA HPI reported that as of August 2025, prices for dental equipment and supplies had risen 5% since the beginning of 2025, drawing on BLS producer price data (State of the U.S. Dental Economy, Q3 2025 Update, slide 15). That was the number everyone treated as a post-disruption hangover: supply chains were healing, so the 5% would flatten and maybe give some back.

It did not flatten. The Producer Price Index for dental equipment and supplies went from 228.679 in August 2025 to 237.065 in August 2026, a 3.6% increase over twelve months (BLS series WPU15650107 via FRED). Stack the two periods and you get about 8.8% on the same basket between the start of 2025 and the most recent print. No shortage required. No crisis headline. Just a price level that reset and then kept climbing at a pace well above anything your PPO schedules moved.

And the PPI understates what lands on your invoice. That index tracks manufacturer-level pricing for equipment and supplies. It does not include lab fees, which are labor-heavy and rising on a labor curve, and it does not capture distributor margin, shifted item mix, or the quiet substitution of a $34 box for a discontinued $27 box. Our own reporting put practice-level increases at 10% to 12% across disposables, anesthetics, restoratives and lab in 2025. The official number and the number on your statement are measuring different things, and the gap between them is yours to absorb.

Shortages Are Events. Price Levels Are Decisions.

This is the piece owners keep missing, and it is not complicated. A shortage is an event with an end. A price level is a decision, and nobody un-decides it voluntarily.

When input costs spiked, manufacturers and distributors raised list prices and told customers it was temporary. When the inputs eased, those list prices became the new base. Rolling them back would require somebody in a consolidated distribution market to start a price war against their own margin, with no competitive gun to their head. Our view: that is not going to happen, and any practice budgeting 2027 on the assumption of mean reversion is budgeting on a fantasy. There is no rebate letter coming.

Which means the right question is not "when do prices come back down." It is "what structural change do I make, given that they do not."

What Most Owners Get Wrong: Auditing the 6% Line and Ignoring the 28%

The specific mistake: owners run a supply audit because the supply line is the one they can see and the vendor rep is a person they can argue with. It feels like control. The practices that do this most religiously are often single-location owner-operators with strong clinical instincts and a long relationship with one distributor, the exact profile that treats cost management as a negotiation skill rather than a structural one.

Meanwhile the bigger erosion ran right past them. The same ADA HPI deck that documented the 5% supply increase shows the dental office staff hourly earnings index at 144 against 129 for equipment and supplies, with January 2015 set to 100 (ADA HPI, Q3 2025). Wages have climbed half again as far as supplies over the same decade. Staff typically runs 25% to 30% of collections. Supplies run 5% to 7%.

So an owner spends twelve hours renegotiating a catalog that represents 6% of collections, wins 8% back on part of it, and books it as a victory worth a few thousand dollars. The same owner has not recalculated their effective PPO reimbursement rate in three years while the line that is four times larger quietly moved against them. We'd put the next ten hours into the payer schedule and the wage plan, not the vendor catalog. Negotiate supplies anyway, it is free money, but stop calling it the project.

Why a 6.7% Fee Raise Nets $2,100 on $1.2 Million

Here is the scenario, because the arithmetic is where this argument gets settled.

Take a general practice collecting $1.2 million. Supplies and lab together ran $143,000 in 2024. Apply the 8.8% cumulative increase from the ADA HPI and BLS figures above and that basket now costs about $155,600, so $12,600 of new cost appears with zero new production.

Staff cost sits at 28% of collections, or $336,000. Say you gave 4% raises in 2026, which given the wage index above is not generous, it is defensive. That is another $13,440. Combined new cost for the year: $26,040.

Now the fee increase. You took the 6.7% average. But a fee increase only becomes revenue on production where your fee is the price. On contracted PPO work you are paid off the carrier's schedule, so raising your UCR does nothing except widen the write-off. If 35% of your production is uncontracted, the raise lands on 35% of the book: 6.7% times 0.35 is an effective 2.35% on total production, or $28,140 on $1.2 million. Net result after the new costs: about $2,100 to the good.

You just ran a fee increase, took the patient-facing friction, and cleared two thousand dollars.

Now make it realistic for a practice in a PPO-dense market where only 25% of production is uncontracted. The raise yields 1.675% effective, or $20,100. Against $26,040 of new cost, that practice is down $5,940 for the year despite doing the thing everyone told them to do.

And the raise made one report look worse. Lifting your UCR against fixed schedules increases your write-off dollars and your write-off percentage. Our view: write-off percentage is the wrong metric to manage. What matters is your effective rate per procedure code against your cost to deliver it. An owner optimizing the write-off line will talk themselves out of a fee increase that was correct, or congratulate themselves on one that was cosmetic.

Drift vs. Erosion: This One Is Erosion

We classify every adverse cost or rate trend with one test, Drift vs. Erosion. Drift is small, steady and recoverable, and you manage it operationally: tighter ordering, formulary discipline, a better distributor agreement. Erosion is structural and compounding, and it requires renegotiation, repricing or exit. Treating erosion as drift is the expensive mistake, because operational fixes against a structural trend buy you one year and then you are back with fewer options.

Through 2024, supply inflation was arguably drift. Twenty-six months later, with the price level up 8.8% and the most recent twelve months still printing 3.6% while reimbursement sat flat, it is erosion. The test is simple: can tighter operations absorb it? A sharp practice can pull 5% to 8% out of a supply budget once. It cannot pull 8% out every year, and it cannot pull anything out of lab fees without changing labs or changing materials.

Erosion response, in order of how much it actually moves: renegotiate or drop your worst PPO contracts, reprice the 25% to 35% of your book where your fee is the price (and reprice it on a schedule, not once), restructure the procedure mix toward work where your margin survives a 4% annual input increase, and if two or three carriers are below your cost to deliver, plan the exit rather than complaining about the schedule for another three years.

Your Overhead Report Will Not Flag This in Time

The reason this stays invisible is that it arrives slowly and your P&L smooths it. The 2025 Dental Economics-Levin Group Annual Practice Survey found 58% of practices reported higher overhead in 2025 than 2024, with an average increase of 4.5% among those practices, down from 5.1% the prior year. That deceleration is the trap. A smaller annual increase on a permanently higher base is not relief.

The same survey found 27% of practices reported overhead growth above 10%. That is the group to pay attention to. A quarter of practices are not experiencing drift at all, and if you are in that group, another vendor negotiation and a 5% fee letter is not a plan. It is a delay.

A good rule: if your supply and lab percentage of collections has moved more than 1.5 points in two years and your effective reimbursement rate has not moved at all, you are not having a cost problem. You are having a pricing problem wearing a cost problem's clothes.

Four Things to Do Before the 2027 Schedules Lock

Pull your 2024 and 2026 year-to-date supply, lab and staff lines as a percentage of collections and put them side by side on one page, because the trend is the finding, not the level. Then calculate your effective reimbursement rate on your top fifteen codes for your three largest carriers and rank them by margin after cost to deliver. Send renegotiation requests on the bottom two this month, before 2027 schedules are set, and build the repricing of your uncontracted fees into a standing annual date instead of a reaction. Assume no price reversal in your 2027 budget, because there is no evidence of one.

We are tracking the next three PPI prints on WPU15650107 and the 2027 PPO schedule cycle. Two consecutive flat or negative quarters plus any major carrier posting a schedule increase above 3% would move this back into drift, and we would say so. Until then, we wouldn't bet a single line of your budget on prices coming back. Shortages end; price levels don't.

If you want to see where your own numbers sit against this, our overhead calculator breaks out supplies, lab and staff as a percentage of collections so you can tell whether your cost line drifted or structurally reset. It takes a few minutes with a recent P&L. Run your own numbers and find out which trend you're actually in.